申请人:Bissantz Caterina
公开号:US20090312327A1
公开(公告)日:2009-12-17
The present invention relates to compounds of formula I
wherein R
1
, R
2
, R
3
, Ar and n are as defined herein and pharmaceutically active salts, racemic mixtures, enantiomers, optical isomers or tautomeric forms thereof. The compounds can be used for the treatment of depression, anxiety or schizophrenia.
本发明涉及式I的化合物,其中R1、R2、R3、Ar和n的定义如本文所述,并且其药用盐、拉克米混合物、对映体、光学异构体或其互变异构体。这些化合物可用于治疗抑郁症、焦虑症或精神分裂症。